
Wednesday, December 11, 2024 10:23:22 AM
i guess all this amazing fluff news that qsep is now manufacturing, means they might have a shareholders meeting in 2025. Maybe New Year’s day in Vegas? i’d love to see Cecil actually have to
answer hard ball question that for some reason all you cheer leaders refuse to ask! No worries i’ll do it for you!

Recent QSEP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 12:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2025 04:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:02:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 08:02:39 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/27/2025 11:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 09:56:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 09:54:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2025 09:02:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 01:08:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 01:06:41 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/27/2024 02:30:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/17/2024 06:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2024 10:08:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 06:06:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 06:58:54 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM